Molecular mechanisms of opioid receptor-dependent signaling and behavior

Al-Hasani R, Bruchas MR (2011). Anesthesiology, 115(6):1363-81 Read More

Abstract

Opioid receptors have been targeted for the treatment of pain and related disorders for thousands of years and remain the most widely used analgesics in the clinic. Mu (μ), kappa (κ), and delta (δ) opioid receptors represent the originally classified receptor subtypes, with opioid receptor like-1 (ORL1) being the least characterized. All four receptors are G-protein coupled and activate inhibitory G proteins. These receptors form homo- and heterodimeric complexes and signal to kinase cascades and scaffold a variety of proteins.The authors discuss classic mechanisms and developments in understanding opioid tolerance and opioid receptor signaling and highlight advances in opioid molecular pharmacology, behavioral pharmacology, and human genetics. The authors put into context how opioid receptor signaling leads to the modulation of behavior with the potential for therapeutic intervention. Finally, the authors conclude there is a continued need for more translational work on opioid receptors in vivo.

Full Text

 

EmailPrintShare
Posted on May 1, 2011
Posted in: Axon Injury & Repair, Neurogenetics, Publications, Therapeutics & Diagnostics Authors: